Related Experiment Video
Updated: Jun 13, 2026
09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Involvement of mast cells in systemic sclerosis
Sonosuke Yukawa1, Kunihiro Yamaoka, Norifumi Sawamukai
1The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health.
Summary
Systemic sclerosis (SSc) involves fibrosis and immune issues, with limited treatment options. Mast cells, implicated in other autoimmune diseases, are proposed as a novel therapeutic target for SSc.
Area of Science:
- Immunology
- Rheumatology
- Pathology
Background:
- Systemic sclerosis (SSc) is a fibrotic disease with unknown etiology.
- Current treatments like corticosteroids and immunosuppressants are often ineffective for SSc.
- Organ involvement in SSc necessitates novel therapeutic strategies.
Purpose of the Study:
- To elucidate the role of mast cells in the pathology of systemic sclerosis.
- To evaluate mast cells as a potential therapeutic target for SSc.
Main Methods:
- Review of existing literature on mast cell function in immune responses.
- Analysis of evidence linking mast cells to autoimmune pathogenesis, including rheumatoid arthritis.
- Extrapolation of mast cell roles to SSc pathology.
Main Results:
- Mast cells are key in allergic and IgE-mediated responses.
- Mast cells bridge innate and adaptive immunity.
- Emerging evidence suggests mast cell involvement in rheumatoid arthritis pathogenesis.
Conclusions:
- Mast cells play a significant role in systemic sclerosis pathology.
- Targeting mast cells represents a promising novel therapeutic strategy for SSc patients.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:38Inflammation
Overview
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...